Please login to the form below

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.

http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/

6th July 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Add my company

Edit my company

Latest content on this profile

Rare diseases and orphan drugs: Our experience and expertise: Research Partnership
Conducting research for publication video: Research Partnership
Conference research case study: How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
Portfolio analysis: Using market research to master communications across a therapeutic category: Research Partnership
EphMRA round up 2018: EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership
Patients’willingness to pay: Considerations when developing an appropriate pricing strategy in self-pay markets
Research Partnership